Objectives: To review the effectiveness of antiseptic oral sprays on oral health.
| INTRODUCTION
Dental plaque is composed of bacterial biofilms that adhere to tooth/ teeth surfaces 1 and is the prime aetiological factor of oral diseases, such as caries and gingivitis. The effects of dental plaque, however, are not merely limited to the oral cavity, as a number of studies have shown associations with systemic health: aspiration pneumonia, 2 bacteremia and other infections. 3 Mechanical plaque removal via toothbrushing and flossing serves as the mainstay of daily oral hygiene and is effective for the maintenance of periodontal health. 4 Supplementary measures such as chemotherapeutic agents [5] [6] [7] and assisted brushing, 8 however, may be warranted in situations in which conventional oral hygiene measures may be compromised. For example, such measures may be advocated following periodontal surgery and intermaxillary fixation, 9 as well as for specific patient groups: (eg. mentally or physically challenged individuals 10 , institutionalized elders 11 , patients with dysphagia 12 , preschool children). 13 Mouthrinses are the most frequently used mode of delivering chemotherapeutic plaque control agents, and their effectiveness has
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been established by numerous studies in recent decades. [14] [15] [16] While gel administration is another commonly used option, its effectiveness as a vehicle for such agents lacks consensus due to differences in the agents and concentrations investigated, as well as the wide variation in the frequency and application method (eg. toothbrushes, trays). 17, 18 Oral sprays 19 may have potential as an alternative delivery method for chemical plaque control agents, especially for physically or mentally challenged patients, many of whom may be unable to follow instructions for mouthrinsing, as well as dysphagic subjects at risk for aspiration of mouthrinses and gels. A limited number of studies have shown that oral sprays are well accepted by patients, and there are fewer side effects than with mouthrinses. 20 Nevertheless, there remains a need to determine the effectiveness of oral sprays in relation to improved clinical oral health.
Therefore, the aim of this systematic review was to assess the efficacy of antiseptic oral sprays in the control of dental plaque and gingivitis. 
| METHODOLOGY

| Search strategy
| Screening and selection
Duplicate papers from the 3 databases were removed. Two reviewers (JZ and NM) screened the papers independently by the title and abstract. Papers were excluded if they did not concern oral sprays or oral health, or were review papers or animal studies. In addition, papers were also excluded if they were not randomized clinical trials (RCTs) or did not include dental plaque or gingival inflammation as outcomes.
Full texts of potentially effective papers were retrieved, read and approved by the two reviewers (JZ and NM). Disagreement between two reviewers was resolved by discussion and consensus. 
| Assessment of heterogeneity
Factors 14 used to assess the heterogeneity of the different studies included study design, duration and subjects, intervention, outcomes, and key findings.
| RESULTS
| Search and selection results
The PubMed, Web of Science and Cochrane library searches resulted in 1043 papers, of which 49 were duplicate papers ( Figure 1 ). The titles and abstracts of 994 papers were screened by two independent reviewers (Kappa = 0.926), and a consensus was reached between reviews after discussion, resulting in the identification of 75 potentially effective papers. After retrieval of the full texts, 20 effective papers were included (Kappa = 1). A total of 55 papers were neither clinical trials, nor related to dental plaque and/or gingival inflammation.
No additional studies were found through reference linkage. Among 20 effective papers, eight studies were amenable to meta-analyses (ie where an identical chemical agent (CHX), concentration (0.2% or 0.12%) and study outcome (PI, GI) were used). No further inclusion/ exclusion criteria such as study duration or patient characteristics were applied in the selection of studies for meta-analysis.
| Risk of bias assessment
The risk of bias assessment was performed for the included 20 RCTs by applying the Cochrane Collaboration's Tool for assessing the risk of bias (Cochrane Handbook for Systematic Reviews of Interventions), and the results are summarized in Figure 1 . The following domains were evaluated at "low," "high" or "unclear" risk of bias: (i) random sequence generation, (ii) allocation concealment, (iii) blinding of participant and personnel, (iv) blinding of outcome assessment, (v) incomplete outcome data, (vi) selective reporting and (vii) other bias. The overall risk of bias for an individual study was judged as follows: low, if all criteria were evaluated to be of low risk; high, if at least one criterion was evaluated to be of high risk; and unclear, if at least one criterion was evaluated to be of unclear risk but no criterion of high risk.
Two studies were evaluated as having a high risk of bias, 25, 26 while the other 18 studies were judged as having an unclear risk of bias.
| Descriptive analysis
The characteristics of the 20 studies are presented in Table 1 The volume of agent sprayed to the teeth ranged from 1.5 mL to 2.88 mL, which was three to four times less than the recommended 10 mL volume for mouthrinses. Furthermore, 12 "spray puffs" was the most popular application frequency in the included studies (10 of 20 studies). Two studies sprayed five puffs, and another three studies sprayed the involved surgical areas only. The remaining studies did not provide additional details pertaining to the method of spray application.
| Effect on dental plaque
Of the 20 RCTs, 14 9,26-30,32-37,39,40 reported significant reductions in dental plaque ranging from 22% to 78%. Of the four studies evaluating both CHX sprays and CHX mouthrinses, two studies 20,38 compared 0.2% CHX spray and 0.12% mouthrinse; one study 31 compared 0.2% CHX spray and 0.2% mouthrinse, and one study 36 
| Effect on gingival inflammation
Among the 20 studies, 11 showed significant improvement in gingival health with 13% to 75% reductions in GI scores. No significant differences were found among the studies comparing CHX spray and mouthrinse. Of the five studies 9, 33, 35, 39, 40 utilizing non-CHX sprays, GI reductions were observed for HA (22.5%), stannous fluoride (54%) and hexetidine (50%). No significant GI improvement was exhibited with the B-HCl spray, while no GI assessment was conducted in the studies assessing the CPC and TRN sprays.
| Effect on staining
Six studies assessed tooth staining, with two studies reporting a significantly higher staining side effect after CHX mouthrinse use, compared to CHX spray. Staining index scores (Shaw and Murray) 41 were shown to be increased by 0.62 for 0.2% CHX mouthrinse in one study 38 while the other study 9 did not provide additional details. No assessments for tooth staining were conducted in the non-CHX studies.
| Meta-analysis
A total of eight studies 9, 20, 30, 31, [34] [35] [36] [37] were amenable for meta-analyses to evaluate the effect of using different CHX spray concentrations on dental plaque and gingival inflammation. Meta-analysis with random effects was used due to the high level of heterogeneity. Three T A B L E 1 Characteristics of the selected studies investigating the effectiveness of antiseptic oral sprays on dental plaque and gingival inflammation outcomes 
| DISCUSSION
The quality of RCTs varied broadly according to Cochrane While Francis et al reported that gel preparations were more effective methods for reducing plaque and gingivitis than mouthrinses and sprays, it was also concluded that sprays were the most popular and widely accepted delivery method for both children and their parents.
An additional effect noted by nursing home staff was that most of the patients participating in the spray programme were more cooperative towards any subsequent oral examination and treatment compared to the patients who did not participate.
The included studies varied widely in terms of spray application protocol, indices used to measure outcomes, targeted subject groups, as well as study duration. The recruited subjects can be classified into systemically healthy adults (6 studies), patients post oral surgery (2 studies), institutionalized elders (2 studies), and mentally challenged (5 studies) or physically challenged patients (5 studies).
The effective papers also differed with respect to their study design. Of the 20 included studies, eight utilized a placebo intervention as the control group. There were two main methods used in the included studies to assess changes in plaque. One was to evaluate the decrease in baseline PI scores while the other was to calculate the increase in PI scores following scaling and prophylaxis. The PI score was close to zero once prophylaxis was carried out at baseline. In this case, the intervention was investigated for its ability to inhibit plaque regrowth. Therefore, only an increase in PI scores could be observed.
On the other hand, if prophylaxis was not performed at baseline, the ability of the intervention to remove established plaque was assessed.
In addition to differences in overall study design, different indices PI Such protocol differences made it difficult to synthesize and interpret the results of many of the studies included in this review. A consensus remains to be established with regard to the optimal frequencies, location, and dosages of spray application, as well as study design and duration.
| Antiseptic agents: CHX
CHX is one of the most widely used and thoroughly investigated antiseptics, with numerous studies having established that CHX is safe, stable and effective in preventing and controlling plaque formation, breaking up existing plaque and inhibiting and reducing the development of gingivitis. [42] [43] [44] A systematic review and metaanalysis 14 reported that subjects using CHX mouthrinse in addition to daily oral hygiene procedures (eg tooth brushing) exhibited reductions of 33% and 26% in plaque and gingival bleeding scores, respectively.
Proprietary CHX mouthrinses are available in a variety of concentrations, with 0.2% and 0.12% CHX concentrations being the most often used. A systematic review 45 comparing the effects of a CHX mouthrinse as reported by prior studies 12, 46 ; however, it is higher than the reduction of 0.52 achieved with the same concentration in gel form. 47 These results suggest that CHX delivered via mouthrinse may have higher antiplaque efficacy than CHX sprays of an equivalent concentration, which may be expected given the larger total volumes of CHX used in mouthrinses. Nevertheless, no significant differences in plaque reduction were observed among direct comparisons between CHX mouthrinses and sprays in the studies 20, 31, 36, 38 included in this review.
| Hexetidine
Ashley et al 48 
| Hyaluronic acid
Hyaluronic Acid (HA) is a glycosaminoglycan with anti-inflammatory properties, and its incorporation into mouthrinses and gels has been found to be effective in reducing plaque regrowth and gingivitis [50] [51] [52] In this review, one study 39 
| Stannous fluoride
| Cetylpyridinium chloride
Cetylpyridinium chloride (CPC) is a quaternary ammonium compound and has been demonstrated to be safe and effective for reducing plaque and gingivitis in a number of studies. 58, 59 Lotufo et al 2009 60 assessed the efficacy of a commercial mouthrinse containing 0.05% CPC in inhibiting plaque growth relative to that of a control rinse without 0.05%
CPC. The result showed a significant reduction in dental plaque buildup (29.3%) for the CPC mouthrinse compared to the control group.
Similar findings were also reported by Pedro et al and Milton et al 61, 62 In an investigation of a 0.05% CPC spray, however, Pizzo et al 9 did not report any significant differences compared with a saline spray in inhibiting plaque regrowth. This may have been due to the small volume of CPC (0.2 mL on each surface) used in the spray application.
| Triclosan
Triclosan (TRN) is a common ingredient in a range of commercial toothpastes and mouthrinses, [63] [64] [65] [66] [67] and its effectiveness has been widely investigated. Schaeken et al 65 
| Benzydamine-HCl
| STUDY LIMITATIONS
Various limitations are acknowledged in this review, such as the restrictions of the search to the English language and published literature. Furthermore, large variations were evident across studies with regards to sample size, selection of subjects, duration of the interventions, and assessment methods. Overall, there is a need to conduct more high-quality studies with standardized procedures in order to enhance the evidence supporting the use of antiseptic oral sprays on clinical oral health.
| CONCLUSIONS
Available evidence suggests that oral sprays are an acceptable delivery method for antiseptic agents. CHX is the most widely investigated antiseptic agent used in oral sprays, and meta-analyses suggested it to be effective in reducing plaque scores and gingival inflammation.
However, considering that bias to some extent existed in the included studies, the findings in this review should be interpreted with caution.
Additional high-quality studies conducted with standardized procedures are warranted to determine optimal protocols for spray application, as well as the potential effectiveness of alternative non-CHX chemotherapeutic agents delivered via oral sprays to improve oral hygiene.
7 | CLINICAL RELEVANCE
| Scientific rationale
Adjunctive measures such as the administration of chemotherapeutic antiplaque agents are important in situations where the ability to implement mechanical plaque removal methods is compromised.
The delivery of chemotherapeutic antiplaque agents in the form of mouthrinses may not be suitable for certain patient groups.
Therefore, there is a need for the evaluation of the effectiveness of oral sprays, a measure which has not yet been systematically reviewed.
| Principle findings
Oral sprays may serve as an effective mode of delivery of chemotherapeutic antiplaque agents.
| Practical implications
It should be of interest to readers in public health and oral health promotion interventions.
